Contact our breast care nurses
0808 800 6000
8 July 2019 The Scottish Medicines Consortium (SMC) has today (8 July 2019) announced its decision to approve palbociclib in combination with...
3 June 2019 The new Interim NHS People Plan was launched on Monday 3 June 2019 to address the workforce challenges the health service is...
Ribociclib (Kisqali, Novartis) is one of a class of drugs known as CDK4/6 inhibitors, which have recently been introduced to NHS care and work by...
The Scottish Medicines Consortium (SMC) has today (13 May 2019) announced its decision to approve breast cancer drug abemaciclib as part of two new...
The National Audit of Breast Cancer in Older Patients (NABCOP), carried out by the Royal College of Surgeons and the Association of Breast Surgery,...
New research presented at the European Congress on Obesity has suggested that nutrients called phenolic acids – which are found in foods such as...
Breast Cancer Care and Breast Cancer Now respond to a report on cancer incidence in Scotland. Ashleigh Simpson, Policy and Campaigns...
The Clinical Risk Assessment report follows a previous report from Health Improvement Scotland which highlighted that patients in NHS Tayside...
The National Institute for Health and Care Excellence (NICE) has today (10 April 2019) provisionally rejected breast cancer drug ribociclib in...
Stay in touch
We’d love to keep in touch about news, events and how you can get involved. To hear from us, enter your email address below.
Connect with us
